Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Stephens, L. A.
Right arrow Articles by Mason, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephens, L. A.
Right arrow Articles by Mason, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 16, No. 2, pp. 365-375, February 2004
© 2004 Japanese Society for Immunology

Phenotypic characterization of regulatory CD4+CD25+ T cells in rats

Leigh A. Stephens1,2, A. Neil Barclay1 and Don Mason1

1 Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK 2 Present address: Institute of Cell, Animal and Population Biology, University of Edinburgh, Edinburgh EH9 3JT, UK

Correspondence to: L. Stephens, Institute of Cell, Animal and Population Biology, University of Edinburgh, Ashworth Laboratories, King’s Buildings, West Mains Road, Edinburgh EH9 3JT, UK. E-mail: leigh.stephens{at}ed.ac.uk
Transmitting editor: T. Hünig

CD25 has become widely used as a marker for a subset of regulatory CD4+ T cells present in the thymus and periphery of mice, rats and humans. However, CD25 is also expressed on conventionally activated T cells that are not regulatory and not all peripheral regulatory T cells express CD25. The identification of a stable and unique marker for regulatory T cells would therefore be valuable. This study provides a detailed account of the phenotype of CD4+CD25+ regulatory T cells in rats. In the thymus, CD4+CD8–CD25+ cells were found to have a more mature phenotype than the corresponding CD4+CD8–CD25– cells with respect to expression of Thy1 (CD90), CD53 and CD44, suggesting that CD25 expression, and perhaps commitment to regulatory function, might be a late event in thymocyte development. CD4+CD25+ cells in both the thymus and periphery were found to have enriched and heterogeneous expression of activation markers such as OX40 (CD134) and OX48 (an antibody determined in this study to be specific for CD86). CD4+CD25+ T cells were also found to have enriched expression of CD80, at both the mRNA and protein level. However, functional studies in vitro and in vivo showed that neither OX40 or CD86 were useful markers for the further subdivision of regulatory T cells. Our studies indicate that, at present, CD25 remains the most useful marker to enrich for regulatory CD4+ T cells in rats and no further subdivision of the regulatory component of CD4+CD25–CD45RClow T cells has yet been achieved.

Keywords: CD4+CD25+, regulatory T cell, tolerance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
E. N. M. Nolte-'t Hoen, E. P. J. Boot, J. P. A. Wagenaar-Hilbers, J. H. M. van Bilsen, G. J. A. Arkesteijn, G. Storm, L. A. Everse, W. van Eden, and M. H. M. Wauben
Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134
J. Leukoc. Biol., January 1, 2008; 83(1): 112 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. D. Easterbrook, M. C. Zink, and S. L. Klein
Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host
PNAS, September 25, 2007; 104(39): 15502 - 15507.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-L. Hillebrands, B. Whalen, J. T. J. Visser, J. Koning, K. D. Bishop, J. Leif, J. Rozing, J. P. Mordes, D. L. Greiner, and A. A. Rossini
A Regulatory CD4+ T Cell Subset in the BB Rat Model of Autoimmune Diabetes Expresses Neither CD25 Nor Foxp3
J. Immunol., December 1, 2006; 177(11): 7820 - 7832.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Beyer, M. Kochanek, T. Giese, E. Endl, M. R. Weihrauch, P. A. Knolle, S. Classen, and J. L. Schultze
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma
Blood, May 15, 2006; 107(10): 3940 - 3949.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Beyer, M. Kochanek, K. Darabi, A. Popov, M. Jensen, E. Endl, P. A. Knolle, R. K. Thomas, M. von Bergwelt-Baildon, S. Debey, et al.
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
Blood, September 15, 2005; 106(6): 2018 - 2025.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.